TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17033926

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy plus tamoxifen for 1 year
Number of subjects: 311

Group type: COMPARATOR
Intervention: CMF chemotherapy for 1 year
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: CMF plus tamoxifen with BCG during the second year
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Patients diagnosed with ER+ tumors
Number of subjects: 311
Study: 15475273

Group type: EXPERIMENTAL
Intervention: Education for asthma management (individual or collective education)
Number of subjects: 66
Study: 11524100

Group type: EXPERIMENTAL
Intervention: Wound dressings
Number of subjects: 45
Study: 9573748

Group type: EXPERIMENTAL
Intervention: Estrogens alone administered transdermically (17 beta‐estradiol, 50 micrograms/day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (0.625 mg/day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Transdermic estrogens plus oral progestagen (17 beta‐estradiol 50 micrograms/day, acetate medroxyprogestogen 10 mg/day for 12 days per month)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (0.625 mg/day) plus oral progestagen (10 mg/day for 12 days per month)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 84
Study: 8179948

Group type: EXPERIMENTAL
Intervention: Intervention practices (n=13)
Number of subjects: 3850

Group type: COMPARATOR
Intervention: Control practices (n=13)
Number of subjects: 3850
Study: 3282825

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 25
Study: 30189674

Group type: EXPERIMENTAL
Intervention: Cleaner-burning biomass-fueled cookstoves
Number of subjects: 1928

Group type: COMPARATOR
Intervention: Location (Chikhwawa versus Chilumba)
Number of subjects: 1928

Group type: EXPERIMENTAL
Intervention: Correlation between mean CO and COHgB
Number of subjects: 1928
Study: 26581073

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 23879294

Group type: EXPERIMENTAL
Intervention: HYPO (hypoxic training, FiO(2) = 15%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NOR (normoxic training, FiO(2) = 20·9%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 22731789

Group type: EXPERIMENTAL
Intervention: Good Outcome (GO) cases of EFT
Number of subjects: 6

Group type: COMPARATOR
Intervention: Poor Outcome (PO) cases of EFT
Number of subjects: 6
Study: 20470802

Group type: EXPERIMENTAL
Intervention: Anti-TNF treatment plus DMARDs
Number of subjects: 63

Group type: COMPARATOR
Intervention: DMARDs only (Control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups (Anti-TNF and Control)
Number of subjects: 63
Study: 18768401

Group type: EXPERIMENTAL
Intervention: Immediate postnatal weight gain (0 to 5 months)
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Weight gain between 1 year and 9 months to 5 years
Number of subjects: 679
Study: 15821690

Group type: EXPERIMENTAL
Intervention: Functional appliances (Fränkel II or Herbst); average treatment duration to final cephalograms: 35.8 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bilateral sagittal split ramus osteotomy; average treatment duration to final cephalograms: 34.9 months
Number of subjects: 60
Study: 12388961

Group type: EXPERIMENTAL
Intervention: Dinoprostone gel 5 mg intracervically, with repeated dosing one time 6 hours later
Number of subjects: 32
Study: 9973008

Group type: EXPERIMENTAL
Intervention: Right ventricular outflow tract (RVOT) pacing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 16
Study: 7588670

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 100 mg suppositories
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 2105670

Group type: EXPERIMENTAL
Intervention: Standard in-line filters
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham in-line filters
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Glycerol-based peripheral hyperalimentation solution (after eliminating in-line filters)
Number of subjects: 88
Study: 477550

Group type: EXPERIMENTAL
Intervention: Theophylline ethylenediamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of theophylline, diprophylline, and proxyphylline
Number of subjects: 0
Study: 31870451

Group type: EXPERIMENTAL
Intervention: Physiotherapy with protein-rich nutritional supplement plus anabolic steroid
Number of subjects: 48

Group type: COMPARATOR
Intervention: Physiotherapy with protein-rich nutritional supplement plus placebo
Number of subjects: 48
Study: 28291238

Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram (ESC)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline (AMI)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 25884358

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate and high calorie oral nutritional supplement
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo medication and low calorie oral nutritional supplementation
Number of subjects: 53
Study: 23621805

Group type: EXPERIMENTAL
Intervention: Individual music therapy for 6 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care for 6 weeks
Number of subjects: 42
Study: 21412143

Group type: EXPERIMENTAL
Intervention: Infrahepatic IVC clamping
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (anesthesiological interventions including fluid restriction)
Number of subjects: 152
Study: 19132197

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day for 10 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clopidogrel 300 mg on day 11
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17324742

Group type: EXPERIMENTAL
Intervention: L-NMMA (3 mg/kg intravenously)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15002070

Group type: EXPERIMENTAL
Intervention: Aprotinin (15,000 IU/kg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (10 mg/kg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Aprotinin group (n = 12)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pentoxifylline group (n = 11)
Number of subjects: 39
Study: 11277274

Group type: EXPERIMENTAL
Intervention: Pamidronate (90 mg single-dose infusion)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 9688484

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Doppler ultrasound studies
Number of subjects: 52
Study: 8083102

Group type: EXPERIMENTAL
Intervention: lonidamine + radiation therapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: placebo + radiation therapy
Number of subjects: 310
Study: 2536765

Group type: EXPERIMENTAL
Intervention: 80 mg fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 338109

Group type: EXPERIMENTAL
Intervention: 2 mg PGE2 in 2% gel
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 5 mg PGE2 in 4% gel
Number of subjects: 168
Study: 30801900

Group type: EXPERIMENTAL
Intervention: Indocyanine green-guided nonpalpable breast cancer lesion localization (INBCL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wire localization (WL)
Number of subjects: 62
Study: 28659419

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNR/comfort care decisions
Number of subjects: 0
Study: 25875943

Group type: EXPERIMENTAL
Intervention: Community weight gain prevention program
Number of subjects: 28
Study: 24887490

Group type: EXPERIMENTAL
Intervention: Group 1: 20 mg/day lutein and 2 mg/day zeaxanthin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Group 2: 10 mg/day meso-zeaxanthin, 10 mg/day lutein, and 2 mg/day zeaxanthin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Group 3: 17 mg/day meso-zeaxanthin, 3 mg/day lutein, and 2 mg/day zeaxanthin
Number of subjects: 52
Study: 22818396

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy oriented group intervention (4-week program)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 156
Study: 19130163

Group type: EXPERIMENTAL
Intervention: Regional anesthesia and/or analgesia
Number of subjects: 1538

Group type: COMPARATOR
Intervention: General anesthesia and/or systemic analgesia
Number of subjects: 1538
Study: 17728216

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (nondirective empathic listening)
Number of subjects: 200
Study: 15588321

Group type: EXPERIMENTAL
Intervention: Mitral valve prolapse (MVP) with celiac artery stenosis (CAS)
Number of subjects: 3780

Group type: COMPARATOR
Intervention: Mitral valve prolapse (MVP) without celiac artery stenosis (CAS)
Number of subjects: 3780

Group type: EXPERIMENTAL
Intervention: Peak Systolic Velocity (PSV) in MVP patients
Number of subjects: 3780
Study: 11783835

Group type: EXPERIMENTAL
Intervention: Exercise for chronic low back pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise for fibromyalgia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise for chronic neck pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise for upper extremity pain (chronic lateral epicondylitis and specific soft tissue shoulder disorders)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise for chronic neck pain and chronic soft tissue shoulder disorders and chronic lateral epicondylitis
Number of subjects: 0
Study: 9338554

Group type: EXPERIMENTAL
Intervention: Topical fluticasone propionate
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups (after antigen challenge)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Topical glucocorticoid therapy
Number of subjects: 17
Study: 7931090

Group type: EXPERIMENTAL
Intervention: Auditory processing of verbal material (Task 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing of emotions shown on faces (Task 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing of visual categorical and coordinate spatial relations (Task 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual processing of verbal material (Task 4)
Number of subjects: 0
Study: 2896471

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 80
Study: 29358446

Group type: EXPERIMENTAL
Intervention: Fast track initiation counselling for patients eligible for antiretroviral therapy (ART)
Number of subjects: 3456

Group type: EXPERIMENTAL
Intervention: Adherence clubs for stable ART patients
Number of subjects: 3456

Group type: EXPERIMENTAL
Intervention: Decentralised medication delivery for stable ART patients
Number of subjects: 3456

Group type: EXPERIMENTAL
Intervention: Enhanced adherence counselling for unstable ART patients
Number of subjects: 3456

Group type: EXPERIMENTAL
Intervention: Early tracing of patients who miss an appointment by ≥5 days
Number of subjects: 3456

Group type: COMPARATOR
Intervention: Standard of care (comparison clinics)
Number of subjects: 3456
Study: 27249416

Group type: EXPERIMENTAL
Intervention: Albumin-adjusted serum anion gap (A-SAG)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 440
Study: 26235790

Group type: EXPERIMENTAL
Intervention: Icare PRO
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tono-Pen
Number of subjects: 50
Study: 23034128

Group type: EXPERIMENTAL
Intervention: Phyllanthus
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 21076158

Group type: EXPERIMENTAL
Intervention: AAD treatment for the first 6 weeks after ablation
Number of subjects: 110

Group type: COMPARATOR
Intervention: No AAD treatment for the first 6 weeks after ablation
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Early AF recurrence (on or off AADs) during the initial 6-week period
Number of subjects: 110
Study: 18215983

Group type: EXPERIMENTAL
Intervention: Protease inhibitor dose escalation in response to therapeutic drug monitoring (TDM) with an inhibitory quotient
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16813838

Group type: EXPERIMENTAL
Intervention: Behavioural intervention programme
Number of subjects: 710

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 710
Study: 14614766

Group type: EXPERIMENTAL
Intervention: Leucocyte IFNalpha 3MU three times weekly plus ribavirin
Number of subjects: 423

Group type: COMPARATOR
Intervention: Recombinant IFNalpha-2b plus ribavirin
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Leucocyte IFNalpha plus ribavirin
Number of subjects: 423
Study: 15493484

Group type: EXPERIMENTAL
Intervention: Structured preparatory information provided by operating room nurses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uninformed patients
Number of subjects: 60
Study: 10421233

Group type: EXPERIMENTAL
Intervention: gliclazide
Number of subjects: 36

Group type: COMPARATOR
Intervention: metformin
Number of subjects: 36
Study: 8532490

Group type: COMPARATOR
Intervention: Familiarization with either the first (target) or the second (distractor) or both odors from a pair, with varying numbers of familiarization sessions (one, two, or three).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiarization with odors (target, distractor, or both).
Number of subjects: 0
Study: 2319467

Group type: EXPERIMENTAL
Intervention: 0.5 mg nicotine gum
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 78

Group type: COMPARATOR
Intervention: 0 mg nicotine gum
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Higher doses (2 mg and 4 mg)
Number of subjects: 78
Study: 493904

Group type: COMPARATOR
Intervention: Cool, dry room air (CDA) at 23 degrees C with 3 mg of water and 7.3 cal of heat content/l
Number of subjects: 5

Group type: COMPARATOR
Intervention: Over-saturated air (OSA) at room temperature containing 43 mg water and 16.3 cal/l
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Warm, humidified air (WHA) at 37 degrees C with 43 mg water and 34.7 cal/l
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hot, dry air (HDA) at 120 degrees C having 3 mg water and 24.4 cal/l
Number of subjects: 5
Study: 31478892

Group type: EXPERIMENTAL
Intervention: Fentanyl (time-weighted cumulative dose above the median)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No fentanyl
Number of subjects: 70
Study: 27926528

Group type: EXPERIMENTAL
Intervention: Ketamine (sub-anesthetic dose of racemic ketamine hydrochloride)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 42
Study: 25439678

Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 136
Study: 23566636

Group type: EXPERIMENTAL
Intervention: High-dose B vitamin therapy
Number of subjects: 3673

Group type: COMPARATOR
Intervention: Low-dose B vitamin therapy
Number of subjects: 3673

Group type: EXPERIMENTAL
Intervention: Low eGFR (<45 mL/min/1.73 m²)
Number of subjects: 3673
Study: 21627339

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (9 MIU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (6 MIU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (3 MIU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunitinib (50 mg)
Number of subjects: 0
Study: 19407523

Group type: EXPERIMENTAL
Intervention: Dilapan-S
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamicel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laminaria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study: 18042575

Group type: EXPERIMENTAL
Intervention: pegylated-interferon alpha (PEG-2a) plus ribavirin (RV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pegylated-interferon alpha (PEG-2a) monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16035641

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no PRP)
Number of subjects: 14
Study: 11708311

Group type: EXPERIMENTAL
Intervention: Soybean oil-based preparation of CoQ10 (300 mg daily for 7 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Complex micelle emulsion of CoQ10 (300 mg daily for 7 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both preparations of CoQ10
Number of subjects: 12
Study: 9149124

Group type: EXPERIMENTAL
Intervention: Carboplatin (CBDCA) administered 10 min after achieving target temperature (41.8 degrees C) during the plateau phase of WBH
Number of subjects: 17

Group type: COMPARATOR
Intervention: Carboplatin (CBDCA) administered on an early schedule before reaching target temperature
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ifosfamide, etoposide, and granulocyte colony stimulating factor delivered during all cycles
Number of subjects: 17
Study: 8189742

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tonic water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief of having consumed alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Belief of having consumed tonic water
Number of subjects: 0
Study: 30027292

Group type: EXPERIMENTAL
Intervention: C-509T allele in TGFB1 gene
Number of subjects: 287

Group type: COMPARATOR
Intervention: No C-509T allele in TGFB1 gene
Number of subjects: 287
Study: 26580349

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (n=26)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 213
Study: 25282112

Group type: EXPERIMENTAL
Intervention: Metformin treatment in PCOS women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 0
Study: 23556486

Group type: EXPERIMENTAL
Intervention: Tapered-shaped polyvinylchloride cuff
Number of subjects: 60

Group type: COMPARATOR
Intervention: Barrel-shaped polyvinylchloride cuff (Control)
Number of subjects: 60
Study: 20514951

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg preoperatively, then 600 mg twice a day for two days postoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 60
Study: 19037955

Group type: EXPERIMENTAL
Intervention: Postural experiences
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Object-oriented experiences
Number of subjects: 42

Group type: COMPARATOR
Intervention: Social experiences (control)
Number of subjects: 42
Study: 17238301

Group type: EXPERIMENTAL
Intervention: Computer-aided diabetes education
Number of subjects: 19
Study: 14714361

Group type: EXPERIMENTAL
Intervention: Fuzheng Yiliu Granule (FZYLG) for 15 days
Number of subjects: 76
Study: 10799426

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microg three times daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 microg)
Number of subjects: 80
Study: 8798121

Group type: EXPERIMENTAL
Intervention: Carotid and vertebral artery transluminal angioplasty
Number of subjects: 193

Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 193
Study: 1461540

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 0
Study: 2857061

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) program
Number of subjects: 12866

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 12866
Study: 30267937

Group type: EXPERIMENTAL
Intervention: Reproductive Life Plan (RLP) tool-based information
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group 1 (CG1)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group 2 (CG2)
Number of subjects: 181
Study: 27887605

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 162

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 162
Study: 24172145

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Antidepressant Medication (ADM)
Number of subjects: 100
Study: 22669133

Group type: EXPERIMENTAL
Intervention: vShield device
Number of subjects: 23

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 23
Study: 19578227

Group type: EXPERIMENTAL
Intervention: LED phototherapy
Number of subjects: 272

Group type: COMPARATOR
Intervention: CFT phototherapy
Number of subjects: 272
Study: 18554731

Group type: EXPERIMENTAL
Intervention: Caffeine (200mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Napping (60-90min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15981783

Group type: EXPERIMENTAL
Intervention: Selective skin cooling over m. vastus lateralis (VL) for 3 min before resting mfMRI and MVC tests, and before, during, and after KEE
Number of subjects: 7

Group type: COMPARATOR
Intervention: No skin cooling (control)
Number of subjects: 7
Study: 12117831

Group type: EXPERIMENTAL
Intervention: Early moderate to severe mitral regurgitation
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Left ventricular thrombosis
Number of subjects: 757
Study: 10407233

Group type: EXPERIMENTAL
Intervention: Treatment exposure (dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random effects model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bootstrap procedure
Number of subjects: 0
Study: 7770495

Group type: EXPERIMENTAL
Intervention: Multichannel functional electrical stimulation (MFES) followed by conventional therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional therapy followed by multichannel functional electrical stimulation (MFES)
Number of subjects: 20